A GFP endometriosis model reveals important morphological characteristics of the angiogenic process that govern benign and malignant diseases.

article OA: closed CC0 ⤵ 10 in-corpus citations
AI-generated summary by claude@2026-06, 2026-06-09

This study established a GFP endometriosis model in mice, revealing similar angiogenic patterns to cancer, with increased vascularization, Vegf, and macrophage infiltration, providing a platform for further endometriosis and anti-angiogenic drug research.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-09 · read from full text

The paper uses a GFP-based mouse endometriosis model to study angiogenesis and lesion morphology, by transplanting endometrial fragments from GFP-mice into the peritoneal cavity of wild-type recipient mice and then analyzing tissue structure and vascular changes. Lesions formed cystic, vascularized tissue with endometrial glands and stroma, and immunostaining and RNAm analyses showed increased vascular density alongside elevated VEGF and its receptor Flk-1, with GFP-labeled fluorescent cells confirming the donor origin. Activated macrophages were also more abundant in the lesions (about a 25% increase by flow cytometry), aligning with an inflammatory–angiogenic link reported in prior work, and the authors note a key limitation that this is an in vivo model designed for studying angiogenesis patterns rather than fully recapitulating all aspects of human disease. This paper is centrally about endometriosis — it establishes and characterizes a GFP endometriosis model focusing on the morphological features and markers of angiogenesis and macrophage-associated inflammation.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Endometriosis involves the growth of endometriotic tissue outside the uterine cavity, and is frequently associated with different malignancies. A well-reported alteration in the disease microenvironment is the proliferation of new blood vessels around the lesions, as part of a necessary repertory to contribute to the invasiveness and development of infiltrating endometriosis. Therefore, the establishment of a reliable experimental model is essential to elucidate the contribution of angiogenesis and to develop new therapeutic approaches to endometriosis treatment. For this purpose we transplanted endometrial fragments from green fluorescent protein (GFP)-mice (n=20) into the peritoneal cavity of wild-type mice (n=20), and then analyzed the morphological changes and the process of angiogenesis. The lesions were cystic and vascularized, and showed morphological hallmarks such as endometrial glands and stroma. An increase in endometriotic lesion vascular density was revealed by immunostaining and RNAm expression for Vegf and its receptor Flk-1, and the lesions were confirmed as a tissue-donor source by GFP fluorescent cells. The same pattern was observed through staining of activated macrophages and an increase of about 25% in the number of macrophage-positive cells was also demonstrated in endometriotic lesions by flow cytometry, which concords with previous data that correlate endometriosis, angiogenesis and inflammation. According to our understanding, this is the first demonstration that the pattern of the angiogenic process in the GFP endometriosis model is very similar to that of cancer. These observations will be useful for investigation of the process of angiogenesis involved in the attachment and invasion of endometrial cells, as well as an in vivo platform model to study the effects of antiangiogenic drugs.
Full text 2,928 characters · extracted from oa-doi-fallback · click to expand
A GFP endometriosis model reveals important morphological characteristics of the angiogenic process that govern benign and malignant diseases Daniel Escorsim Machado1,2, Antônio Palumbo Júnior2, João Marcos Santos1, Rômulo Medina Mattos2, Thiago Alves dos Santos1, Sergio Henrique Seabra1, Leonardo da Cunha Boldrini2, Jamila Alessandra Perini1 and Luiz Eurico Nasciutti2 1Health and Biological Sciences Center, Pharmacy College, State University of East Zone, Rio de Janeiro, Brazil and 2Development and Cell Biology Research Program, Biomedical Sciences Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil Offprint requests to: Luiz Eurico Nasciutti, Laboratório de Interaçoes Celulares, Programa de Pesquisa em Biologia Celular e do Desenvolvimento, Instituto de Ciencias Biomédicas, Universidade Federal do Rio de Janeiro, Cidade Universitária - Ilha do Fundao, 21941-590, Rio de Janeiro, Brazil. e-mail: [email protected] Summary. Endometriosis involves the growth of endometriotic tissue outside the uterine cavity, and is frequently associated with different malignancies. A well-reported alteration in the disease microenvironment is the proliferation of new blood vessels around the lesions, as part of a necessary repertory to contribute to the invasiveness and development of infiltrating endometriosis. Therefore, the establishment of a reliable experimental model is essential to elucidate the contribution of angiogenesis and to develop new therapeutic approaches to endometriosis treatment. For this purpose we transplanted endometrial fragments from green fluorescent protein (GFP)-mice (n=20) into the peritoneal cavity of wild-type mice (n=20), and then analyzed the morphological changes and the process of angiogenesis. The lesions were cystic and vascularized, and showed morphological hallmarks such as endometrial glands and stroma. An increase in endometriotic lesion vascular density was revealed by immunostaining and RNAm expression for Vegf and its receptor Flk-1, and the lesions were confirmed as a tissue-donor source by GFP fluorescent cells. The same pattern was observed through staining of activated macrophages and an increase of about 25% in the number of macrophage-positive cells was also demonstrated in endometriotic lesions by flow cytometry, which concords with previous data that correlate endometriosis, angiogenesis and inflammation. According to our understanding, this is the first demonstration that the pattern of the angiogenic process in the GFP endometriosis model is very similar to that of cancer. These observations will be useful for investigation of the process of angiogenesis involved in the attachment and invasion of endometrial cells, as well as an in vivo platform model to study the effects of antiangiogenic drugs. Histol Histopathol 29, 903-912 (2014) Key words: Endometriosis, GFP mice, Angiogenesis, VEGF DOI: 10.14670/HH-29.903

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Disease Models, Animal Endometriosis Neovascularization, Pathologic Animals Endometriosis Female Flow Cytometry Fluorescent Antibody Technique Green Fluorescent Proteins Mice Mice, Inbred C57BL Mice, Transgenic Neovascularization, Pathologic Reverse Transcriptase Polymerase Chain Reaction

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (10)

Source provenance

europepmc
last seen: 2026-07-26T06:08:39.051465+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:18:40.923139+00:00
License: CC0 · commercial use OK